These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16440359)

  • 1. FibroScan and FibroTest to assess liver fibrosis in HCV with normal aminotransferases.
    Castera L; Foucher J; Bertet J; Couzigou P; de Ledinghen V
    Hepatology; 2006 Feb; 43(2):373-4; author reply 375-6. PubMed ID: 16440359
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic value of FibroTest with normal serum aminotransferases.
    Poynard T; Munteanu M; Ngo Y; Torres M; Benhamou Y; Thabut D; Ratziu V
    Hepatology; 2006 Feb; 43(2):374-5; author reply 375-6. PubMed ID: 16440358
    [No Abstract]   [Full Text] [Related]  

  • 3. Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases.
    Colletta C; Smirne C; Fabris C; Toniutto P; Rapetti R; Minisini R; Pirisi M
    Hepatology; 2005 Oct; 42(4):838-45. PubMed ID: 16121354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: a step toward the truth in the absence of a gold standard.
    Poynard T; de Ledinghen V; Zarski JP; Stanciu C; Munteanu M; Vergniol J; France J; Trifan A; Le Naour G; Vaillant JC; Ratziu V; Charlotte F;
    J Hepatol; 2012 Mar; 56(3):541-8. PubMed ID: 21889468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of hepatic fibrosis in patients with chronic hepatitis C.
    Albanis E; Friedman SL
    Clin Liver Dis; 2006 Nov; 10(4):821-33. PubMed ID: 17164119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discordance between biochemical markers of liver activity and fibrosis (Actitest-Fibrotest) and liver biopsy in patients with chronic hepatitis C.
    Fontanges T; Bailly F; Trepo E; Chevallier M; Maynard-Muet M; Nalet B; Beorchia S; Pillon D; Moindrot H; Froissart B; Slaoui M; Tinel X; Pradat P; Trepo C
    Gastroenterol Clin Biol; 2008 Oct; 32(10):858-65. PubMed ID: 18775614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new combination of blood test and fibroscan for accurate non-invasive diagnosis of liver fibrosis stages in chronic hepatitis C.
    Boursier J; de Ledinghen V; Zarski JP; Rousselet MC; Sturm N; Foucher J; Leroy V; Fouchard-Hubert I; Bertrais S; Gallois Y; Oberti F; Dib N; Calès P
    Am J Gastroenterol; 2011 Jul; 106(7):1255-63. PubMed ID: 21468012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of enhanced liver fibrosis test to assess liver fibrosis in chronic hepatitis C virus and alcoholic liver disease patients.
    Soto M; Sampietro-Colom L; Lasalvia L; Mira A; Jiménez W; Navasa M
    World J Gastroenterol; 2017 May; 23(17):3163-3173. PubMed ID: 28533673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroscan and FibroTest/FibroMax to assess liver fibrosis/cirrhosis in patients with chronic HBV and HCV infection in Georgia.
    Dolmazashvili E; Zhamutashvili M; Svanidze M; Nizharadze N; Abutidze A
    Georgian Med News; 2008 Dec; (165):83-7. PubMed ID: 19124923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient elastography--an alternative to liver biopsy in patients with chronic hepatitis C?
    Stanciu C; Trifan A; Cojocariu C
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(4):765-70. PubMed ID: 17438875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-invasive fibrosis assessment in chronic hepatitis C: aspartate-aminotransferase to platelet ratio index (APRI) and transient elastography (FibroScan)].
    Pár A; Pár G
    Orv Hetil; 2010 Nov; 151(47):1951-5. PubMed ID: 21071307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
    Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P
    J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Retrospective study of FibroScan, APRI, FIB-4 and FORNS indexes compared with liver biopsy in the evaluation of liver fibrosis in patients with chronic hepatitis C monoinfection and HIV coinfection].
    González Guilabert MI; Hinojosa Mena-Bernal C; del Pozo González J; del Pozo Pérez MA
    Gastroenterol Hepatol; 2010; 33(6):425-32. PubMed ID: 20471720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive tests for liver fibrosis: encouraging or discouraging results?
    Burroughs AK; Cholongitas E
    J Hepatol; 2007 May; 46(5):751-5. PubMed ID: 17383047
    [No Abstract]   [Full Text] [Related]  

  • 15. Prospective evaluation of FibroTest®, FibroMeter®, and HepaScore® for staging liver fibrosis in chronic hepatitis B: comparison with hepatitis C.
    Leroy V; Sturm N; Faure P; Trocme C; Marlu A; Hilleret MN; Morel F; Zarski JP
    J Hepatol; 2014 Jul; 61(1):28-34. PubMed ID: 24631902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive assessment of liver steatosis, fibrosis and inflammation in chronic hepatitis C virus infection.
    Schneider AR; Teuber G; Kriener S; Caspary WF
    Liver Int; 2005 Dec; 25(6):1150-5. PubMed ID: 16343065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Measurement of liver elasticity can differentiate high and low grade fibrosis. New method can reduce the need of liver biopsy in chronic hepatitis C].
    Wejdmark A; Weiland O
    Lakartidningen; 2009 Dec 9-21; 106(50-51):3420-3. PubMed ID: 20180445
    [No Abstract]   [Full Text] [Related]  

  • 18. Ultrasound evaluation of the fibrosis stage in chronic liver disease by the simultaneous use of low and high frequency probes.
    Nishiura T; Watanabe H; Ito M; Matsuoka Y; Yano K; Daikoku M; Yatsuhashi H; Dohmen K; Ishibashi H
    Br J Radiol; 2005 Mar; 78(927):189-97. PubMed ID: 15730982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic accuracy of the Forns index, platelet count and AST to Platelet Ratio Index derived fibrosis index for the prediction of Hepatitis C virus-related significant liver fibrosis and cirrhosis.
    Kayadibi H; Yasar B; Ozkara S; Serdar MA; Kurdas OO; Gonen C
    Scand J Clin Lab Invest; 2014 Apr; 74(3):240-7. PubMed ID: 24460024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gray and color Doppler ultrasonography in differentiation between chronic viral hepatitis and compensated early stage cirrhosis.
    Iliopoulos P; Vlychou M; Margaritis V; Tsamis I; Tepetes K; Petsas T; Karatza C
    J Gastrointestin Liver Dis; 2007 Sep; 16(3):279-86. PubMed ID: 17925922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.